IGF1 and amyotrophic lateral sclerosis: IGF-1 has been shown to decrease disease pathology and progression in animal models of ALS [76] and spinal and bulbar muscular atrophy [77], as well as alleviate symptoms in a mouse model of diabetic peripheral neuropathy [78].